Neuroone Medical Technologies (NMTC) Cash from Investing Activities (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neuroone Medical Technologies | 31.39 Mn | 28.59 Mn | 1.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.49% |
| Dec 31, 2025 | -284.22% |
| Sep 30, 2025 | 75.64% |
| Jun 30, 2025 | -1,273.32% |
| Mar 31, 2025 | 87.01% |
| Dec 31, 2024 | 33.84% |
| Sep 30, 2024 | -149.34% |
| Jun 30, 2024 | 52.80% |
| Mar 31, 2024 | 15.54% |
| Dec 31, 2023 | 25.92% |
| Sep 30, 2023 | -105.82% |
| Jun 30, 2023 | -52.82% |
| Mar 31, 2023 | 12,006.35% |
| Dec 31, 2022 | 100.50% |
| Sep 30, 2022 | -5,497.45% |
| Jun 30, 2022 | 41.88% |
| Mar 31, 2022 | -51.76% |
| Dec 31, 2021 | -75.14% |
| Sep 30, 2021 | -17.38% |
| Sep 30, 2020 | -118.07% |
| Jun 30, 2020 | 13.72% |
| Mar 31, 2020 | -191.63% |
| Dec 31, 2019 | -133.43% |
| Sep 30, 2019 | 91.84% |
| Jun 30, 2018 | -59.97% |
| Mar 31, 2018 | 0.00% |